SAB Biotherapeutics Gets FDA Fast-Track for Flu Treatment SAB-176
By Dean Seal SAB Biotherapeutics Inc. said regulators have granted fast-track designation to SAB-176, its investigational therapeutic for Type A and Type B influenza. The Sioux Falls,... | April 13, 2023
Alexandra Kropotova Biotherapeutics Inc Drug Administration Dean Seal Sioux Falls Medical Officer Alexandra Kropotova
Source: marketscreener.com